Logotype for Algorhythm Holdings Inc

Algorhythm Holdings (RIME) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Algorhythm Holdings Inc

Proxy Filing summary

1 Dec, 2025

Executive summary

  • The annual meeting will be held virtually on November 20, 2025, with seven director seats up for election and several key proposals on the agenda.

  • Proposals include a reverse stock split, reincorporation from Delaware to Nevada, an amendment to the equity incentive plan, approval of a pre-paid financing transaction, auditor ratification, and potential adjournment to solicit more proxies.

  • The board recommends voting in favor of all proposals, citing strategic, financial, and governance benefits.

  • Forward-looking statements highlight risks and uncertainties, especially regarding compliance with Nasdaq listing requirements and the impact of corporate actions.

Voting matters and shareholder proposals

  • Shareholders will vote on electing seven directors, a reverse stock split (1-for-2 to 1-for-10), reincorporation to Nevada, increasing shares under the 2022 Equity Incentive Plan to 5,000,000, issuing shares in a pre-paid financing, auditor ratification, and adjournment if needed.

  • The board unanimously recommends voting “FOR” all proposals.

  • Shareholder proposals for the 2026 meeting must be submitted by June 23, 2026, for inclusion in the proxy statement.

Board of directors and corporate governance

  • The board consists of seven members, four of whom are independent under Nasdaq rules.

  • Committees include Audit, Compensation, Nominating and Corporate Governance, and Executive, all with independent directors.

  • The board is responsible for risk oversight, with specific risks delegated to committees.

  • Directors are elected by plurality; no cumulative voting is allowed.

  • The company has adopted a Code of Ethics and has no known change of control arrangements.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more